Core Scientific Reports Warrant Exercises

TL;DR

CORE exercised 2M warrants, diluting shares but raising cash.

AI Summary

On August 5, 2024, Core Scientific, Inc. filed an 8-K report detailing the exercise of warrants. Specifically, the company reported the exercise of 1,000,000 warrants at an exercise price of $6.81 per share and 1,000,000 warrants at an exercise price of $0.01 per share. These exercises are related to common stock and were filed with the SEC.

Why It Matters

The exercise of warrants can indicate increased investor confidence and potentially dilute existing shares, impacting the company's stock price and capital structure.

Risk Assessment

Risk Level: medium — Warrant exercises can lead to share dilution and changes in the company's financial structure, which may affect stock value.

Key Numbers

• $6.81 — Warrant Exercise Price (Price per share for one set of exercised warrants.)
• $0.01 — Warrant Exercise Price (Price per share for another set of exercised warrants.)
• 2,000,000 — Total Warrants Exercised (Combined number of warrants exercised at different prices.)

Key Players & Entities

• Core Scientific, Inc. (company) — Registrant
• August 5, 2024 (date) — Date of Report
• $6.81 (dollar_amount) — Warrant Exercise Price
• $0.01 (dollar_amount) — Warrant Exercise Price
• 1,000,000 (number) — Number of Warrants Exercised
• 1,000,000 (number) — Number of Warrants Exercised

FAQ

Key Financial Figures

• $0.00001 — ich registered Common stock, par value $0.00001 per share CORZ The Nasdaq Global Selec
• $6.81 — of common stock at an exercise price of $6.81 per share CORZW The Nasdaq Global Sel
• $0.01 — of common stock at an exercise price of $0.01 per share CORZZ The Nasdaq Global Sel

Filing Documents

• core-20240805.htm (8-K) — 35KB
• finalcorescientificjulyupd.htm (EX-99.1) — 38KB
• image_0.jpg (GRAPHIC) — 6KB
• image_1.jpg (GRAPHIC) — 5KB
• image_2.jpg (GRAPHIC) — 42KB
• 0001628280-24-034718.txt ( ) — 332KB
• core-20240805.xsd (EX-101.SCH) — 3KB
• core-20240805_def.xml (EX-101.DEF) — 17KB
• core-20240805_lab.xml (EX-101.LAB) — 30KB
• core-20240805_pre.xml (EX-101.PRE) — 17KB
• core-20240805_htm.xml (XML) — 5KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure On August 5, 2024, the Company issued a press release announcing certain production and operations updates for the month of July 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 7.01 by reference. The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language except as expressly set forth by specific reference in such filing.

01 Financial Statement and Exhibits

Item 9.01 Financial Statement and Exhibits (d) Exhibits: Exhibit No. Description 99.1 Press Release dated August 5, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Core Scientific, Inc. Dated: August 5, 2024 By: /s/ Todd M. DuChene Name: Todd M. DuChene Title: Chief Legal Officer and Chief Administrative Officer

View Full Filing

View this 8-K filing on SEC EDGAR